Evaxion Biotech Company
Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.
Founded Date:
2008-01-01
Technology:
Biotechnology
Funding Status:
IPO
Total Funding:
400000000
Employee Number:
51-100
Headquarters:
Copenhagen, Hovedstaden, Denmark
Last Funding Date:
2022-09-06
Investors Number:
2.0
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$1M to $10M
Industry:
Immunotherapy Development